Compile Data Set for Download or QSAR

Found 585 hits with Last Name = 'knudsen' and Initial = 'lb'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Glucagon receptor (Homo sapiens (Human))	BDBM50068641 (2-(5-tert-Butyl-1H-benzoimidazol-2-ylsulfanyl)-1-(...) Show SMILES CC(C)(C)c1ccc2nc(SCC(=O)c3ccc(O)c(O)c3)[nH]c2c1 Show InChI InChI=1S/C19H20N2O3S/c1-19(2,3)12-5-6-13-14(9-12)21-18(20-13)25-10-17(24)11-4-7-15(22)16(23)8-11/h4-9,22-23H,10H2,1-3H3,(H,20,21)	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	5.40E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068631 (3-{2-[2-(3-Chloro-4-hydroxy-phenyl)-2-oxo-ethylsul...) Show SMILES COC(=O)c1cccc(COc2ccc3nc(SCC(=O)c4ccc(O)c(Cl)c4)[nH]c3c2)c1 Show InChI InChI=1S/C24H19ClN2O5S/c1-31-23(30)16-4-2-3-14(9-16)12-32-17-6-7-19-20(11-17)27-24(26-19)33-13-22(29)15-5-8-21(28)18(25)10-15/h2-11,28H,12-13H2,1H3,(H,26,27)	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	9.20E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068620 (2-(1H-Benzoimidazol-2-ylsulfanyl)-1-(3-chloro-4-hy...) Show SMILES Oc1ccc(cc1Cl)C(=O)CSc1nc2ccccc2[nH]1 Show InChI InChI=1S/C15H11ClN2O2S/c16-10-7-9(5-6-13(10)19)14(20)8-21-15-17-11-3-1-2-4-12(11)18-15/h1-7,19H,8H2,(H,17,18)	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	1.20E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068626 (3-{2-[2-(3,4-Dihydroxy-phenyl)-2-oxo-ethylsulfanyl...) Show SMILES COC(=O)c1cccc(COc2ccc3nc(SCC(=O)c4ccc(O)c(O)c4)[nH]c3c2)c1 Show InChI InChI=1S/C24H20N2O6S/c1-31-23(30)16-4-2-3-14(9-16)12-32-17-6-7-18-19(11-17)26-24(25-18)33-13-22(29)15-5-8-20(27)21(28)10-15/h2-11,27-28H,12-13H2,1H3,(H,25,26)	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	1.60E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068614 (2-(5-Benzyloxy-1H-benzoimidazol-2-ylsulfanyl)-1-(3...) Show SMILES Oc1ccc(cc1O)C(=O)CSc1nc2ccc(OCc3ccccc3)cc2[nH]1 Show InChI InChI=1S/C22H18N2O4S/c25-19-9-6-15(10-20(19)26)21(27)13-29-22-23-17-8-7-16(11-18(17)24-22)28-12-14-4-2-1-3-5-14/h1-11,25-26H,12-13H2,(H,23,24)	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	1.80E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068636 (2-(1H-Benzoimidazol-2-ylsulfanyl)-1-(3,4-dihydroxy...) Show SMILES Oc1ccc(cc1O)C(=O)CSc1nc2ccccc2[nH]1 Show InChI InChI=1S/C15H12N2O3S/c18-12-6-5-9(7-13(12)19)14(20)8-21-15-16-10-3-1-2-4-11(10)17-15/h1-7,18-19H,8H2,(H,16,17)	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid UniChem Similars	Article PubMed	2.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Compound was evaluated for its binding affinity towards cloned human Glucagon receptor in BHK cells				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068627 (2-(5,6-Dichloro-1H-benzoimidazol-2-ylsulfanyl)-1-(...) Show SMILES Oc1ccc(cc1O)C(=O)CSc1nc2cc(Cl)c(Cl)cc2[nH]1 Show InChI InChI=1S/C15H10Cl2N2O3S/c16-8-4-10-11(5-9(8)17)19-15(18-10)23-6-14(22)7-1-2-12(20)13(21)3-7/h1-5,20-21H,6H2,(H,18,19)	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	2.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068616 (2-(1H-Benzoimidazol-2-ylsulfanyl)-1-(4-hydroxy-3-m...) Show SMILES COc1cc(ccc1O)C(=O)CSc1nc2ccccc2[nH]1 Show InChI InChI=1S/C16H14N2O3S/c1-21-15-8-10(6-7-13(15)19)14(20)9-22-16-17-11-4-2-3-5-12(11)18-16/h2-8,19H,9H2,1H3,(H,17,18)	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	4.10E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM45955 (1-(3,4-dihydroxyphenyl)-2-[(6-methoxy-1H-benzimida...) Show SMILES COc1ccc2nc(SCC(=O)c3ccc(O)c(O)c3)[nH]c2c1 Show InChI InChI=1S/C16H14N2O4S/c1-22-10-3-4-11-12(7-10)18-16(17-11)23-8-15(21)9-2-5-13(19)14(20)6-9/h2-7,19-20H,8H2,1H3,(H,17,18)	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid UniChem Similars	Article PubMed	4.20E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM32012 (1-(3,4-Dihydroxy-phenyl)-2-(5-phenyl-4H-[1,2,4]tri...) Show SMILES Oc1ccc(cc1O)C(=O)CSc1nnc([nH]1)-c1ccccc1 Show InChI InChI=1S/C16H13N3O3S/c20-12-7-6-11(8-13(12)21)14(22)9-23-16-17-15(18-19-16)10-4-2-1-3-5-10/h1-8,20-21H,9H2,(H,17,18,19)	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	5.50E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068633 (1-(3,4-Dihydroxy-phenyl)-2-(5-nitro-1H-benzoimidaz...) Show SMILES Oc1ccc(cc1O)C(=O)CSc1nc2ccc(cc2[nH]1)[N+]([O-])=O Show InChI InChI=1S/C15H11N3O5S/c19-12-4-1-8(5-13(12)20)14(21)7-24-15-16-10-3-2-9(18(22)23)6-11(10)17-15/h1-6,19-20H,7H2,(H,16,17)	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid UniChem	Article PubMed	5.50E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068630 (2-(1H-Benzoimidazol-2-ylsulfanyl)-1-(4-hydroxy-phe...) Show SMILES Oc1ccc(cc1)C(=O)CSc1nc2ccccc2[nH]1 Show InChI InChI=1S/C15H12N2O2S/c18-11-7-5-10(6-8-11)14(19)9-20-15-16-12-3-1-2-4-13(12)17-15/h1-8,18H,9H2,(H,16,17)	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid UniChem Similars	Article PubMed	>6.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068618 (2-(Benzothiazol-2-ylsulfanyl)-1-(3,4-dihydroxy-phe...) Show SMILES Oc1ccc(cc1O)C(=O)CSc1nc2ccccc2s1 Show InChI InChI=1S/C15H11NO3S2/c17-11-6-5-9(7-12(11)18)13(19)8-20-15-16-10-3-1-2-4-14(10)21-15/h1-7,17-18H,8H2	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid UniChem	Article PubMed	7.30E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068617 (3-{2-[2-(3,4-Dihydroxy-phenyl)-2-oxo-ethylsulfanyl...) Show SMILES OC(=O)c1cccc(COc2ccc3nc(SCC(=O)c4ccc(O)c(O)c4)[nH]c3c2)c1 Show InChI InChI=1S/C23H18N2O6S/c26-19-7-4-14(9-20(19)27)21(28)12-32-23-24-17-6-5-16(10-18(17)25-23)31-11-13-2-1-3-15(8-13)22(29)30/h1-10,26-27H,11-12H2,(H,24,25)(H,29,30)	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	9.50E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068634 (1-(3,4-Dihydroxy-phenyl)-2-(quinolin-2-ylsulfanyl)...) Show SMILES Oc1ccc(cc1O)C(=O)CSc1ccc2ccccc2n1 Show InChI InChI=1S/C17H13NO3S/c19-14-7-5-12(9-15(14)20)16(21)10-22-17-8-6-11-3-1-2-4-13(11)18-17/h1-9,19-20H,10H2	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid UniChem	Article PubMed	1.60E+5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068637 (1-(3,4-Dihydroxy-phenyl)-2-(4,5-diphenyl-1H-imidaz...) Show SMILES Oc1ccc(cc1O)C(=O)CSc1nc(c([nH]1)-c1ccccc1)-c1ccccc1 Show InChI InChI=1S/C23H18N2O3S/c26-18-12-11-17(13-19(18)27)20(28)14-29-23-24-21(15-7-3-1-4-8-15)22(25-23)16-9-5-2-6-10-16/h1-13,26-27H,14H2,(H,24,25)	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	1.80E+5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068643 (5-[2-(1H-Benzoimidazol-2-ylsulfanyl)-acetyl]-2-hyd...) Show SMILES OC(=O)c1cc(ccc1O)C(=O)CSc1nc2ccccc2[nH]1 Show InChI InChI=1S/C16H12N2O4S/c19-13-6-5-9(7-10(13)15(21)22)14(20)8-23-16-17-11-3-1-2-4-12(11)18-16/h1-7,19H,8H2,(H,17,18)(H,21,22)	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	2.00E+5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068635 (2-(Benzooxazol-2-ylsulfanyl)-1-(3,4-dihydroxy-phen...) Show SMILES Oc1ccc(cc1O)C(=O)CSc1nc2ccccc2o1 Show InChI InChI=1S/C15H11NO4S/c17-11-6-5-9(7-12(11)18)13(19)8-21-15-16-10-3-1-2-4-14(10)20-15/h1-7,17-18H,8H2	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid UniChem Similars	Article PubMed	2.50E+5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068628 (2-(1H-Benzoimidazol-2-ylsulfanyl)-1-(3-hydroxy-phe...) Show SMILES Oc1cccc(c1)C(=O)CSc1nc2ccccc2[nH]1 Show InChI InChI=1S/C15H12N2O2S/c18-11-5-3-4-10(8-11)14(19)9-20-15-16-12-6-1-2-7-13(12)17-15/h1-8,18H,9H2,(H,16,17)	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	3.80E+5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068621 (2-(1H-Benzoimidazol-2-ylsulfanyl)-1-(3,4-dichloro-...) Show SMILES Clc1ccc(cc1Cl)C(=O)CSc1nc2ccccc2[nH]1 Show InChI InChI=1S/C15H10Cl2N2OS/c16-10-6-5-9(7-11(10)17)14(20)8-21-15-18-12-3-1-2-4-13(12)19-15/h1-7H,8H2,(H,18,19)	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid UniChem Similars	Article PubMed	>5.00E+5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068619 (2-(1H-Benzoimidazol-2-ylsulfanyl)-1-(3,4-dihydroxy...) Show SMILES CCCC(Sc1nc2ccccc2[nH]1)C(=O)c1ccc(O)c(O)c1 Show InChI InChI=1S/C18H18N2O3S/c1-2-5-16(17(23)11-8-9-14(21)15(22)10-11)24-18-19-12-6-3-4-7-13(12)20-18/h3-4,6-10,16,21-22H,2,5H2,1H3,(H,19,20)	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	>5.00E+5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068642 (2-(1H-Benzoimidazol-2-ylsulfanyl)-1-phenyl-ethanon...) Show SMILES O=C(CSc1nc2ccccc2[nH]1)c1ccccc1 Show InChI InChI=1S/C15H12N2OS/c18-14(11-6-2-1-3-7-11)10-19-15-16-12-8-4-5-9-13(12)17-15/h1-9H,10H2,(H,16,17)	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid UniChem Similars	Article PubMed	>5.00E+5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068615 (2-(1H-Benzoimidazol-2-ylsulfanyl)-1-(3,4-dimethoxy...) Show SMILES COc1ccc(cc1OC)C(=O)CSc1nc2ccccc2[nH]1 Show InChI InChI=1S/C17H16N2O3S/c1-21-15-8-7-11(9-16(15)22-2)14(20)10-23-17-18-12-5-3-4-6-13(12)19-17/h3-9H,10H2,1-2H3,(H,18,19)	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid UniChem Similars	Article PubMed	>5.00E+5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068640 (1-(3,4-Dihydroxy-phenyl)-2-(1-methyl-1H-benzoimida...) Show SMILES Cn1c(SCC(=O)c2ccc(O)c(O)c2)nc2ccccc12 Show InChI InChI=1S/C16H14N2O3S/c1-18-12-5-3-2-4-11(12)17-16(18)22-9-15(21)10-6-7-13(19)14(20)8-10/h2-8,19-20H,9H2,1H3	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid UniChem Similars	Article PubMed	>5.00E+5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068639 (2-(1H-Benzoimidazol-2-ylsulfanyl)-1-(3-chloro-4-hy...) Show SMILES Oc1ccc(cc1Cl)C(CSc1nc2ccccc2[nH]1)N=O Show InChI InChI=1S/C15H12ClN3O2S/c16-10-7-9(5-6-14(10)20)13(19-21)8-22-15-17-11-3-1-2-4-12(11)18-15/h1-7,13,20H,8H2,(H,17,18)	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	>5.00E+5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068613 (4-[2-(1H-Benzoimidazol-2-ylsulfanyl)-1-hydroxy-eth...) Show SMILES OC(CSc1nc2ccccc2[nH]1)c1ccc(O)c(Cl)c1 Show InChI InChI=1S/C15H13ClN2O2S/c16-10-7-9(5-6-13(10)19)14(20)8-21-15-17-11-3-1-2-4-12(11)18-15/h1-7,14,19-20H,8H2,(H,17,18)	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	>5.00E+5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068632 (2-(1H-Benzoimidazol-2-ylsulfanyl)-1-(3-chloro-4-hy...) Show SMILES Oc1ccc(cc1Cl)C(\CSc1nc2ccccc2[nH]1)=N/OCc1ccccc1 Show InChI InChI=1S/C22H18ClN3O2S/c23-17-12-16(10-11-21(17)27)20(26-28-13-15-6-2-1-3-7-15)14-29-22-24-18-8-4-5-9-19(18)25-22/h1-12,27H,13-14H2,(H,24,25)/b26-20-	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	>5.00E+5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50408685 (CHEMBL2112026) Show SMILES Oc1cc(O)cc(c1)C(=O)CSc1nc2ccccc2[nH]1 Show InChI InChI=1S/C15H12N2O3S/c18-10-5-9(6-11(19)7-10)14(20)8-21-15-16-12-3-1-2-4-13(12)17-15/h1-7,18-19H,8H2,(H,16,17)	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	>5.00E+5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068622 (4-(1H-Benzoimidazol-2-ylsulfanyl)-1-(3,4-dihydroxy...) Show SMILES Oc1ccc(cc1O)C(=O)CCCSc1nc2ccccc2[nH]1 Show InChI InChI=1S/C17H16N2O3S/c20-14(11-7-8-15(21)16(22)10-11)6-3-9-23-17-18-12-4-1-2-5-13(12)19-17/h1-2,4-5,7-8,10,21-22H,3,6,9H2,(H,18,19)	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	>5.00E+5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068623 (1-(3,4-Dihydroxy-phenyl)-2-(1H-imidazol-2-ylsulfan...) Show SMILES Oc1ccc(cc1O)C(=O)CSc1ncc[nH]1 Show InChI InChI=1S/C11H10N2O3S/c14-8-2-1-7(5-9(8)15)10(16)6-17-11-12-3-4-13-11/h1-5,14-15H,6H2,(H,12,13)	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid UniChem Similars	Article PubMed	>5.00E+5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068625 (3-[2-(1H-Benzoimidazol-2-ylsulfanyl)-acetyl]-benzo...) Show SMILES OC(=O)c1cccc(c1)C(=O)CSc1nc2ccccc2[nH]1 Show InChI InChI=1S/C16H12N2O3S/c19-14(10-4-3-5-11(8-10)15(20)21)9-22-16-17-12-6-1-2-7-13(12)18-16/h1-8H,9H2,(H,17,18)(H,20,21)	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	>5.00E+5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068624 (2-(1H-Benzoimidazol-2-ylsulfanyl)-1-(3-chloro-4-hy...) Show SMILES CO\N=C(\CSc1nc2ccccc2[nH]1)c1ccc(O)c(Cl)c1 Show InChI InChI=1S/C16H14ClN3O2S/c1-22-20-14(10-6-7-15(21)11(17)8-10)9-23-16-18-12-4-2-3-5-13(12)19-16/h2-8,21H,9H2,1H3,(H,18,19)/b20-14-	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	>5.00E+5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon receptor (Homo sapiens (Human))	BDBM50068629 (4-[2-(1H-Benzoimidazol-2-ylsulfanyl)-acetyl]-benzo...) Show SMILES OC(=O)c1ccc(cc1)C(=O)CSc1nc2ccccc2[nH]1 Show InChI InChI=1S/C16H12N2O3S/c19-14(10-5-7-11(8-6-10)15(20)21)9-22-16-17-12-3-1-2-4-13(12)18-16/h1-8H,9H2,(H,17,18)(H,20,21)	PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	>5.00E+5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Binding affinity towards cloned human glucagon receptor in BHK cells.				J Med Chem 41: 5150-7 (1999) Article DOI: 10.1021/jm9810304 BindingDB Entry DOI: 10.7270/Q24F1PV6
					More data for this Ligand-Target Pair
Glucagon-like peptide 1 receptor (Homo sapiens (Human))	BDBM50121523 (CHEMBL3616742) Show SMILES CCCCCCCCCCCCCCCC(=O)N[C@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)NCCCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)C(O)=O |r| Show InChI InChI=1S/C191H300N46O60/c1-19-21-22-23-24-25-26-27-28-29-30-31-38-54-144(246)216-131(187(289)290)60-65-143(245)200-72-75-292-78-82-296-102-149(251)202-74-77-294-80-83-297-103-150(252)201-73-76-293-79-81-295-101-148(250)199-69-42-41-51-126(170(272)219-130(63-68-153(257)258)171(273)224-135(86-115-45-34-32-35-46-115)176(278)235-158(109(11)20-2)184(286)213-112(14)163(265)221-137(89-118-92-205-123-50-40-39-49-121(118)123)174(276)223-133(85-106(5)6)175(277)233-156(107(7)8)182(284)220-125(53-44-71-204-190(196)197)166(268)206-94-145(247)214-124(52-43-70-203-189(194)195)165(267)209-97-155(261)262)217-162(264)111(13)211-161(263)110(12)212-169(271)129(59-64-142(193)244)215-146(248)95-207-167(269)127(61-66-151(253)254)218-172(274)132(84-105(3)4)222-173(275)134(88-117-55-57-120(243)58-56-117)225-179(281)139(98-238)228-181(283)141(100-240)229-183(285)157(108(9)10)234-178(280)138(91-154(259)260)226-180(282)140(99-239)230-186(288)160(114(16)242)236-177(279)136(87-116-47-36-33-37-48-116)227-185(287)159(113(15)241)232-147(249)96-208-168(270)128(62-67-152(255)256)231-188(291)191(17,18)237-164(266)122(192)90-119-93-198-104-210-119/h32-37,39-40,45-50,55-58,92-93,104-114,122,124-141,156-160,205,238-243H,19-31,38,41-44,51-54,59-91,94-103,192H2,1-18H3,(H2,193,244)(H,198,210)(H,199,250)(H,200,245)(H,201,252)(H,202,251)(H,206,268)(H,207,269)(H,208,270)(H,209,267)(H,211,263)(H,212,271)(H,213,286)(H,214,247)(H,215,248)(H,216,246)(H,217,264)(H,218,274)(H,219,272)(H,220,284)(H,221,265)(H,222,275)(H,223,276)(H,224,273)(H,225,281)(H,226,282)(H,227,287)(H,228,283)(H,229,285)(H,230,288)(H,231,291)(H,232,249)(H,233,277)(H,234,280)(H,235,278)(H,236,279)(H,237,266)(H,253,254)(H,255,256)(H,257,258)(H,259,260)(H,261,262)(H,289,290)(H4,194,195,203)(H4,196,197,204)/t109-,110-,111-,112-,113+,114+,122-,124-,125-,126-,127-,128-,129-,130-,131+,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,156-,157-,158-,159-,160-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL MMDB PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.0300	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Displacement of [125I]-GLP1 from human GLP1 receptor expressed in BHK cells after 2 hrs in absence of human serum albumin				J Med Chem 58: 7370-80 (2015) Article DOI: 10.1021/acs.jmedchem.5b00726 BindingDB Entry DOI: 10.7270/Q2TX3H6D
					More data for this Ligand-Target Pair
Glucagon-like peptide 1 receptor (Homo sapiens (Human))	BDBM50120380 (CHEMBL3616743) Show SMILES CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)NCCCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)C(O)=O |r| Show InChI InChI=1S/C187H293N45O57/c1-19-21-22-23-24-25-26-27-28-29-30-31-32-33-40-56-141(241)211-128(183(283)284)62-67-140(240)196-74-76-286-78-81-289-100-146(246)197-75-77-287-79-80-288-99-145(245)195-71-44-43-53-123(166(266)214-127(65-70-149(251)252)167(267)219-132(84-112-47-36-34-37-48-112)172(272)230-154(106(11)20-2)180(280)208-109(14)159(259)216-134(87-115-90-200-120-52-42-41-51-118(115)120)170(270)218-130(83-103(5)6)171(271)228-152(104(7)8)178(278)215-122(55-46-73-199-186(192)193)162(262)201-92-142(242)209-121(54-45-72-198-185(190)191)161(261)204-95-151(255)256)212-158(258)108(13)206-157(257)107(12)207-165(265)126(61-66-139(189)239)210-143(243)93-202-163(263)124(63-68-147(247)248)213-168(268)129(82-102(3)4)217-169(269)131(86-114-57-59-117(238)60-58-114)220-175(275)136(96-233)223-177(277)138(98-235)224-179(279)153(105(9)10)229-174(274)135(89-150(253)254)221-176(276)137(97-234)225-182(282)156(111(16)237)231-173(273)133(85-113-49-38-35-39-50-113)222-181(281)155(110(15)236)227-144(244)94-203-164(264)125(64-69-148(249)250)226-184(285)187(17,18)232-160(260)119(188)88-116-91-194-101-205-116/h34-39,41-42,47-52,57-60,90-91,101-111,119,121-138,152-156,200,233-238H,19-33,40,43-46,53-56,61-89,92-100,188H2,1-18H3,(H2,189,239)(H,194,205)(H,195,245)(H,196,240)(H,197,246)(H,201,262)(H,202,263)(H,203,264)(H,204,261)(H,206,257)(H,207,265)(H,208,280)(H,209,242)(H,210,243)(H,211,241)(H,212,258)(H,213,268)(H,214,266)(H,215,278)(H,216,259)(H,217,269)(H,218,270)(H,219,267)(H,220,275)(H,221,276)(H,222,281)(H,223,277)(H,224,279)(H,225,282)(H,226,285)(H,227,244)(H,228,271)(H,229,274)(H,230,272)(H,231,273)(H,232,260)(H,247,248)(H,249,250)(H,251,252)(H,253,254)(H,255,256)(H,283,284)(H4,190,191,198)(H4,192,193,199)/t106-,107-,108-,109-,110+,111+,119-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,152-,153-,154-,155-,156-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.0400	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Displacement of [125I]-GLP1 from human GLP1 receptor expressed in BHK cells after 2 hrs in absence of human serum albumin				J Med Chem 58: 7370-80 (2015) Article DOI: 10.1021/acs.jmedchem.5b00726 BindingDB Entry DOI: 10.7270/Q2TX3H6D
					More data for this Ligand-Target Pair
Glucagon-like peptide 1 receptor (Homo sapiens (Human))	BDBM50121399 (CHEMBL3616764) Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O |r| Show InChI InChI=1S/C187H291N43O59/c1-18-106(10)155(181(280)206-109(13)160(259)214-134(87-115-90-198-120-51-40-39-50-118(115)120)171(270)216-130(83-103(4)5)172(271)226-153(104(6)7)179(278)213-122(52-41-43-71-188)163(262)199-92-142(240)207-121(54-45-73-197-186(191)192)162(261)202-95-152(255)256)228-173(272)132(84-112-46-33-31-34-47-112)217-168(267)127(65-70-150(251)252)212-167(266)123(53-42-44-72-194-145(243)99-288-80-79-287-77-75-196-146(244)100-289-81-78-286-76-74-195-140(238)67-62-128(184(283)284)209-141(239)55-37-29-27-25-23-21-19-20-22-24-26-28-30-38-56-147(245)246)210-159(258)108(12)204-158(257)107(11)205-166(265)126(61-66-139(190)237)208-143(241)93-200-164(263)124(63-68-148(247)248)211-169(268)129(82-102(2)3)215-170(269)131(86-114-57-59-117(236)60-58-114)218-176(275)136(96-231)221-178(277)138(98-233)222-180(279)154(105(8)9)227-175(274)135(89-151(253)254)219-177(276)137(97-232)223-183(282)157(111(15)235)229-174(273)133(85-113-48-35-32-36-49-113)220-182(281)156(110(14)234)225-144(242)94-201-165(264)125(64-69-149(249)250)224-185(285)187(16,17)230-161(260)119(189)88-116-91-193-101-203-116/h31-36,39-40,46-51,57-60,90-91,101-111,119,121-138,153-157,198,231-236H,18-30,37-38,41-45,52-56,61-89,92-100,188-189H2,1-17H3,(H2,190,237)(H,193,203)(H,194,243)(H,195,238)(H,196,244)(H,199,262)(H,200,263)(H,201,264)(H,202,261)(H,204,257)(H,205,265)(H,206,280)(H,207,240)(H,208,241)(H,209,239)(H,210,258)(H,211,268)(H,212,266)(H,213,278)(H,214,259)(H,215,269)(H,216,270)(H,217,267)(H,218,275)(H,219,276)(H,220,281)(H,221,277)(H,222,279)(H,223,282)(H,224,285)(H,225,242)(H,226,271)(H,227,274)(H,228,272)(H,229,273)(H,230,260)(H,245,246)(H,247,248)(H,249,250)(H,251,252)(H,253,254)(H,255,256)(H,283,284)(H4,191,192,197)/t106-,107-,108-,109-,110+,111+,119-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,153-,154-,155-,156-,157-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.0600	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Displacement of [125I]-GLP1 from human GLP1 receptor expressed in BHK cells after 2 hrs in absence of human serum albumin				J Med Chem 58: 7370-80 (2015) Article DOI: 10.1021/acs.jmedchem.5b00726 BindingDB Entry DOI: 10.7270/Q2TX3H6D
					More data for this Ligand-Target Pair
Glucagon-like peptide 1 receptor (Homo sapiens (Human))	BDBM50121405 (CHEMBL3616767) Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O |r| Show InChI InChI=1S/C191H300N44O59/c1-18-109(10)158(185(285)210-112(13)163(263)219-138(91-118-94-203-123-53-40-39-52-121(118)123)175(275)221-134(87-106(4)5)176(276)231-156(107(6)7)183(283)218-125(54-41-44-74-192)166(266)204-96-146(245)211-124(57-47-77-202-190(196)197)165(265)206-98-155(259)260)233-177(277)136(88-115-48-33-31-34-49-115)222-172(272)131(68-73-153(255)256)216-169(269)126(55-42-45-75-193)213-162(262)111(12)208-161(261)110(11)209-168(268)129(64-69-143(195)242)215-170(270)127(56-43-46-76-199-148(247)102-293-84-83-292-81-79-201-149(248)103-294-85-82-291-80-78-200-144(243)70-65-132(188(288)289)212-145(244)58-37-29-27-25-23-21-19-20-22-24-26-28-30-38-59-150(249)250)214-171(271)130(67-72-152(253)254)217-173(273)133(86-105(2)3)220-174(274)135(90-117-60-62-120(241)63-61-117)223-180(280)140(99-236)226-182(282)142(101-238)227-184(284)157(108(8)9)232-179(279)139(93-154(257)258)224-181(281)141(100-237)228-187(287)160(114(15)240)234-178(278)137(89-116-50-35-32-36-51-116)225-186(286)159(113(14)239)230-147(246)97-205-167(267)128(66-71-151(251)252)229-189(290)191(16,17)235-164(264)122(194)92-119-95-198-104-207-119/h31-36,39-40,48-53,60-63,94-95,104-114,122,124-142,156-160,203,236-241H,18-30,37-38,41-47,54-59,64-93,96-103,192-194H2,1-17H3,(H2,195,242)(H,198,207)(H,199,247)(H,200,243)(H,201,248)(H,204,266)(H,205,267)(H,206,265)(H,208,261)(H,209,268)(H,210,285)(H,211,245)(H,212,244)(H,213,262)(H,214,271)(H,215,270)(H,216,269)(H,217,273)(H,218,283)(H,219,263)(H,220,274)(H,221,275)(H,222,272)(H,223,280)(H,224,281)(H,225,286)(H,226,282)(H,227,284)(H,228,287)(H,229,290)(H,230,246)(H,231,276)(H,232,279)(H,233,277)(H,234,278)(H,235,264)(H,249,250)(H,251,252)(H,253,254)(H,255,256)(H,257,258)(H,259,260)(H,288,289)(H4,196,197,202)/t109-,110-,111-,112-,113+,114+,122-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,156-,157-,158-,159-,160-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.0600	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Displacement of [125I]-GLP1 from human GLP1 receptor expressed in BHK cells after 2 hrs in absence of human serum albumin				J Med Chem 58: 7370-80 (2015) Article DOI: 10.1021/acs.jmedchem.5b00726 BindingDB Entry DOI: 10.7270/Q2TX3H6D
					More data for this Ligand-Target Pair
Glucagon-like peptide 1 receptor (Homo sapiens (Human))	BDBM50121527 (CHEMBL3616718) Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O |r| Show InChI InChI=1S/C152H230N42O47/c1-18-77(10)120(146(238)171-80(13)125(217)178-104(60-86-63-163-91-36-26-25-35-89(86)91)136(228)180-100(56-74(4)5)137(229)190-118(75(6)7)144(236)177-93(39-30-54-162-151(158)159)128(220)164-65-110(202)172-92(38-29-53-161-150(156)157)127(219)167-68-117(213)214)192-138(230)102(57-83-31-21-19-22-32-83)181-133(225)98(47-51-115(209)210)176-132(224)94(37-27-28-52-153)174-124(216)79(12)169-123(215)78(11)170-131(223)97(44-48-109(155)201)173-111(203)66-165-129(221)95(45-49-113(205)206)175-134(226)99(55-73(2)3)179-135(227)101(59-85-40-42-88(200)43-41-85)182-141(233)106(69-195)185-143(235)108(71-197)186-145(237)119(76(8)9)191-140(232)105(62-116(211)212)183-142(234)107(70-196)187-148(240)122(82(15)199)193-139(231)103(58-84-33-23-20-24-34-84)184-147(239)121(81(14)198)189-112(204)67-166-130(222)96(46-50-114(207)208)188-149(241)152(16,17)194-126(218)90(154)61-87-64-160-72-168-87/h19-26,31-36,40-43,63-64,72-82,90,92-108,118-122,163,195-200H,18,27-30,37-39,44-62,65-71,153-154H2,1-17H3,(H2,155,201)(H,160,168)(H,164,220)(H,165,221)(H,166,222)(H,167,219)(H,169,215)(H,170,223)(H,171,238)(H,172,202)(H,173,203)(H,174,216)(H,175,226)(H,176,224)(H,177,236)(H,178,217)(H,179,227)(H,180,228)(H,181,225)(H,182,233)(H,183,234)(H,184,239)(H,185,235)(H,186,237)(H,187,240)(H,188,241)(H,189,204)(H,190,229)(H,191,232)(H,192,230)(H,193,231)(H,194,218)(H,205,206)(H,207,208)(H,209,210)(H,211,212)(H,213,214)(H4,156,157,161)(H4,158,159,162)/t77-,78-,79-,80-,81+,82+,90-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,118-,119-,120-,121-,122-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.0800	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Displacement of [125I]-GLP1 from human GLP1 receptor expressed in BHK cells after 2 hrs in presence of 2% human serum albumin				J Med Chem 58: 7370-80 (2015) Article DOI: 10.1021/acs.jmedchem.5b00726 BindingDB Entry DOI: 10.7270/Q2TX3H6D
					More data for this Ligand-Target Pair
Glucagon-like peptide 1 receptor (Homo sapiens (Human))	BDBM50121402 (CHEMBL3616772) Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(O)=O |r| Show InChI InChI=1S/C193H303N49O60/c1-18-108(10)158(184(291)217-111(13)163(270)226-137(89-117-92-209-122-51-40-39-50-120(117)122)174(281)228-133(85-105(4)5)175(282)238-156(106(6)7)182(289)225-124(54-44-74-207-191(198)199)166(273)211-94-145(252)218-123(53-43-73-206-190(196)197)165(272)210-96-147(254)221-130(187(294)295)52-41-42-72-203-149(256)101-301-82-81-300-79-77-205-150(257)102-302-83-80-299-78-76-204-143(250)68-63-131(188(296)297)220-144(251)56-37-29-27-25-23-21-19-20-22-24-26-28-30-38-57-151(258)259)240-176(283)135(86-114-46-33-31-34-47-114)229-171(278)129(66-71-154(264)265)224-170(277)125(55-45-75-208-192(200)201)222-162(269)110(12)215-161(268)109(11)216-169(276)128(62-67-142(195)249)219-146(253)95-212-167(274)126(64-69-152(260)261)223-172(279)132(84-104(2)3)227-173(280)134(88-116-58-60-119(248)61-59-116)230-179(286)139(98-243)233-181(288)141(100-245)234-183(290)157(107(8)9)239-178(285)138(91-155(266)267)231-180(287)140(99-244)235-186(293)160(113(15)247)241-177(284)136(87-115-48-35-32-36-49-115)232-185(292)159(112(14)246)237-148(255)97-213-168(275)127(65-70-153(262)263)236-189(298)193(16,17)242-164(271)121(194)90-118-93-202-103-214-118/h31-36,39-40,46-51,58-61,92-93,103-113,121,123-141,156-160,209,243-248H,18-30,37-38,41-45,52-57,62-91,94-102,194H2,1-17H3,(H2,195,249)(H,202,214)(H,203,256)(H,204,250)(H,205,257)(H,210,272)(H,211,273)(H,212,274)(H,213,275)(H,215,268)(H,216,276)(H,217,291)(H,218,252)(H,219,253)(H,220,251)(H,221,254)(H,222,269)(H,223,279)(H,224,277)(H,225,289)(H,226,270)(H,227,280)(H,228,281)(H,229,278)(H,230,286)(H,231,287)(H,232,292)(H,233,288)(H,234,290)(H,235,293)(H,236,298)(H,237,255)(H,238,282)(H,239,285)(H,240,283)(H,241,284)(H,242,271)(H,258,259)(H,260,261)(H,262,263)(H,264,265)(H,266,267)(H,294,295)(H,296,297)(H4,196,197,206)(H4,198,199,207)(H4,200,201,208)/t108-,109-,110-,111-,112+,113+,121-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,156-,157-,158-,159-,160-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.0900	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Displacement of [125I]-GLP1 from human GLP1 receptor expressed in BHK cells after 2 hrs in absence of human serum albumin				J Med Chem 58: 7370-80 (2015) Article DOI: 10.1021/acs.jmedchem.5b00726 BindingDB Entry DOI: 10.7270/Q2TX3H6D
					More data for this Ligand-Target Pair
Glucagon-like peptide 1 receptor (Homo sapiens (Human))	BDBM50121526 (CHEMBL3616762) Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCCCC(O)=O)C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O |r| Show InChI InChI=1S/C189H295N45O59/c1-18-107(10)156(182(284)210-110(13)161(263)218-135(88-116-91-202-121-52-42-41-51-119(116)121)172(274)220-131(84-104(4)5)173(275)230-154(105(6)7)180(282)217-123(55-46-74-201-188(194)195)164(266)203-93-143(244)211-122(54-45-73-200-187(192)193)163(265)206-96-153(259)260)232-174(276)133(85-113-47-35-33-36-48-113)221-169(271)128(66-71-151(255)256)216-168(270)124(53-43-44-72-197-146(247)100-292-81-80-291-78-76-199-147(248)101-293-82-79-290-77-75-198-141(242)68-63-129(185(287)288)213-142(243)56-39-31-29-27-25-23-21-19-20-22-24-26-28-30-32-40-57-148(249)250)214-160(262)109(12)208-159(261)108(11)209-167(269)127(62-67-140(191)241)212-144(245)94-204-165(267)125(64-69-149(251)252)215-170(272)130(83-103(2)3)219-171(273)132(87-115-58-60-118(240)61-59-115)222-177(279)137(97-235)225-179(281)139(99-237)226-181(283)155(106(8)9)231-176(278)136(90-152(257)258)223-178(280)138(98-236)227-184(286)158(112(15)239)233-175(277)134(86-114-49-37-34-38-50-114)224-183(285)157(111(14)238)229-145(246)95-205-166(268)126(65-70-150(253)254)228-186(289)189(16,17)234-162(264)120(190)89-117-92-196-102-207-117/h33-38,41-42,47-52,58-61,91-92,102-112,120,122-139,154-158,202,235-240H,18-32,39-40,43-46,53-57,62-90,93-101,190H2,1-17H3,(H2,191,241)(H,196,207)(H,197,247)(H,198,242)(H,199,248)(H,203,266)(H,204,267)(H,205,268)(H,206,265)(H,208,261)(H,209,269)(H,210,284)(H,211,244)(H,212,245)(H,213,243)(H,214,262)(H,215,272)(H,216,270)(H,217,282)(H,218,263)(H,219,273)(H,220,274)(H,221,271)(H,222,279)(H,223,280)(H,224,285)(H,225,281)(H,226,283)(H,227,286)(H,228,289)(H,229,246)(H,230,275)(H,231,278)(H,232,276)(H,233,277)(H,234,264)(H,249,250)(H,251,252)(H,253,254)(H,255,256)(H,257,258)(H,259,260)(H,287,288)(H4,192,193,200)(H4,194,195,201)/t107-,108-,109-,110-,111+,112+,120-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,154-,155-,156-,157-,158-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.100	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Displacement of [125I]-GLP1 from human GLP1 receptor expressed in BHK cells after 2 hrs in absence of human serum albumin				J Med Chem 58: 7370-80 (2015) Article DOI: 10.1021/acs.jmedchem.5b00726 BindingDB Entry DOI: 10.7270/Q2TX3H6D
					More data for this Ligand-Target Pair
Glucagon-like peptide 1 receptor (Homo sapiens (Human))	BDBM50121508 (CHEMBL3616774) Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCCCCCCCCCCCCCCCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O |r| Show InChI InChI=1S/C180H280N44O56/c1-16-102(10)150(176(274)202-105(13)155(253)210-129(82-111-85-193-116-48-38-37-47-114(111)116)166(264)212-125(78-99(4)5)167(265)221-148(100(6)7)174(272)209-118(51-42-68-192-180(185)186)158(256)195-88-137(234)203-117(50-41-67-191-179(183)184)157(255)198-91-147(249)250)223-168(266)127(79-108-43-31-29-32-44-108)213-163(261)123(61-65-145(245)246)208-162(260)119(49-39-40-66-188-140(237)95-279-75-74-278-72-70-190-141(238)96-280-76-73-277-71-69-189-135(232)52-35-27-25-23-21-19-17-18-20-22-24-26-28-36-53-142(239)240)206-154(252)104(12)200-153(251)103(11)201-161(259)122(58-62-134(182)231)205-138(235)89-196-160(258)121(60-64-144(243)244)207-164(262)124(77-98(2)3)211-165(263)126(81-110-54-56-113(230)57-55-110)214-171(269)131(92-225)217-173(271)133(94-227)218-175(273)149(101(8)9)222-170(268)130(84-146(247)248)215-172(270)132(93-226)219-178(276)152(107(15)229)224-169(267)128(80-109-45-33-30-34-46-109)216-177(275)151(106(14)228)220-139(236)90-197-159(257)120(59-63-143(241)242)204-136(233)87-194-156(254)115(181)83-112-86-187-97-199-112/h29-34,37-38,43-48,54-57,85-86,97-107,115,117-133,148-152,193,225-230H,16-28,35-36,39-42,49-53,58-84,87-96,181H2,1-15H3,(H2,182,231)(H,187,199)(H,188,237)(H,189,232)(H,190,238)(H,194,254)(H,195,256)(H,196,258)(H,197,257)(H,198,255)(H,200,251)(H,201,259)(H,202,274)(H,203,234)(H,204,233)(H,205,235)(H,206,252)(H,207,262)(H,208,260)(H,209,272)(H,210,253)(H,211,263)(H,212,264)(H,213,261)(H,214,269)(H,215,270)(H,216,275)(H,217,271)(H,218,273)(H,219,276)(H,220,236)(H,221,265)(H,222,268)(H,223,266)(H,224,267)(H,239,240)(H,241,242)(H,243,244)(H,245,246)(H,247,248)(H,249,250)(H4,183,184,191)(H4,185,186,192)/t102-,103-,104-,105-,106+,107+,115-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,148-,149-,150-,151-,152-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.100	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Displacement of [125I]-GLP1 from human GLP1 receptor expressed in BHK cells after 2 hrs in absence of human serum albumin				J Med Chem 58: 7370-80 (2015) Article DOI: 10.1021/acs.jmedchem.5b00726 BindingDB Entry DOI: 10.7270/Q2TX3H6D
					More data for this Ligand-Target Pair
Glucagon-like peptide 1 receptor (Homo sapiens (Human))	BDBM50121518 (CHEMBL428139) Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(O)=O |wU:119.121,95.99,89.93,105.111,142.150,8.16,195.200,134.137,69.74,28.34,210.215,223.228,156.159,164.169,167.172,42.43,176.180,2.2,wD:113.117,123.133,101.103,203.208,4.4,181.184,77.87,19.25,47.53,60.66,37.38,151.154,(42.46,-37.33,;42.37,-38.87,;40.99,-39.57,;39.7,-38.74,;40.89,-41.1,;42.2,-41.97,;43.56,-41.27,;43.68,-39.74,;44.87,-42.13,;44.77,-43.67,;43.39,-44.36,;42.09,-43.51,;40.71,-44.19,;40.63,-45.74,;41.92,-46.56,;43.3,-45.88,;46.26,-41.41,;48.15,-38.22,;50.19,-38.22,;47.05,-35.91,;45.48,-36.01,;44.58,-34.7,;43,-34.7,;42.23,-33.32,;42.2,-36.08,;47.71,-34.5,;46.82,-33.25,;45.29,-33.35,;47.5,-31.88,;49.02,-31.71,;49.9,-33.02,;51.45,-32.86,;52.3,-34.13,;53.88,-34.01,;46.61,-30.57,;47.28,-29.18,;48.81,-29.04,;46.4,-27.9,;44.85,-28.05,;47.1,-26.52,;46.18,-25.27,;44.66,-25.37,;46.88,-23.89,;48.41,-23.75,;45.97,-22.6,;46.65,-21.19,;48.2,-21.08,;45.79,-19.94,;44.22,-20.08,;43.56,-21.45,;42.02,-21.57,;41.15,-20.3,;41.38,-22.93,;46.44,-18.58,;45.53,-17.27,;44.01,-17.37,;46.23,-15.88,;45.34,-14.62,;46.02,-13.23,;47.54,-13.1,;45.15,-11.97,;43.61,-12.08,;42.91,-13.45,;41.38,-13.59,;40.52,-12.3,;40.73,-14.97,;45.81,-10.56,;44.94,-9.3,;43.4,-9.41,;45.62,-7.92,;47.14,-7.76,;47.99,-9.02,;47.37,-10.45,;49.57,-8.92,;44.71,-6.63,;45.37,-5.25,;46.93,-5.14,;44.5,-3.99,;43,-4.11,;42.31,-5.49,;43.19,-6.74,;42.53,-8.16,;40.99,-8.27,;40.3,-9.63,;40.07,-6.99,;40.77,-5.6,;45.15,-2.58,;44.28,-1.32,;43.19,-2.21,;44.97,.09,;46.51,.19,;47.37,-1.06,;44.05,1.35,;42.74,.58,;42.74,-.96,;41.38,1.35,;41.38,2.88,;42.74,3.65,;40.07,.58,;38.72,1.35,;38.72,2.88,;37.4,.58,;36.05,1.35,;34.73,.58,;34.73,-.96,;33.4,1.35,;33.4,2.88,;34.73,3.65,;36.05,2.88,;34.73,5.21,;32.06,.58,;30.7,1.35,;30.7,2.88,;29.39,.58,;29.39,-.96,;30.7,-1.72,;28.01,1.35,;26.72,.58,;26.72,-.96,;25.34,1.35,;24.03,.58,;22.71,1.35,;22.71,2.88,;21.34,.58,;21.34,-.96,;22.71,-1.72,;24.03,-.96,;25.34,-1.72,;25.34,-3.24,;24.03,-4.06,;22.71,-3.24,;20.04,1.35,;18.69,.58,;18.69,-.96,;17.34,1.35,;16,.58,;14.66,1.35,;14.66,2.88,;13.31,.58,;11.99,1.35,;10.66,.58,;10.66,-.96,;9.3,1.35,;9.3,2.88,;10.66,3.65,;10.66,5.21,;9.3,5.97,;11.99,5.97,;7.98,.58,;6.63,1.35,;6.63,2.88,;5.32,.58,;5.32,-.96,;3.97,1.35,;2.61,.58,;2.61,-.96,;1.3,1.35,;-.02,.58,;1.3,2.88,;2.61,3.65,;4.03,3.04,;5.09,4.18,;4.29,5.54,;2.79,5.21,;17.34,2.88,;16,3.65,;18.69,3.65,;25.34,2.88,;24.03,3.65,;26.72,3.65,;37.4,-.96,;36.05,-1.72,;38.72,-1.72,;39.51,-41.81,;39.42,-43.34,;38.22,-40.98,;36.86,-41.69,;36.79,-43.21,;35.55,-40.81,;35.64,-39.3,;34.19,-41.52,;32.88,-40.66,;32.98,-39.14,;31.68,-38.27,;30.24,-38.81,;29.25,-37.61,;30.14,-36.35,;29.72,-34.87,;30.8,-33.77,;32.32,-34.17,;32.71,-35.65,;31.62,-36.77,;31.52,-41.36,;31.41,-42.91,;30.21,-40.54,;28.83,-41.24,;28.76,-42.74,;27.37,-43.45,;27.31,-44.97,;26.09,-42.6,;27.52,-40.38,;27.62,-38.81,;26.16,-41.08,;24.85,-40.23,;24.97,-38.71,;23.66,-37.83,;26.33,-37.99,;23.49,-40.94,;23.42,-42.46,;22.22,-40.07,;20.82,-40.78,;20.71,-42.3,;19.35,-43.02,;19.28,-44.54,;17.91,-45.25,;17.83,-46.77,;19.51,-39.93,;19.62,-38.38,;18.15,-40.65,;16.87,-39.79,;15.48,-40.49,;15.41,-42.03,;14.17,-39.63,;12.81,-40.33,;12.72,-41.87,;11.36,-42.58,;11.27,-44.1,;9.89,-44.8,;9.8,-46.34,;8.44,-47.05,;11.1,-47.16,;11.5,-39.5,;11.6,-37.94,;10.17,-40.21,;8.86,-39.35,;7.45,-40.07,;6.14,-39.2,;7.38,-41.57,)| Show InChI InChI=1S/C151H228N40O47/c1-17-77(10)121(148(236)169-81(14)127(215)177-105(60-87-63-160-92-36-25-24-35-90(87)92)138(226)179-101(56-74(4)5)139(227)188-119(75(6)7)146(234)176-94(37-26-28-52-152)130(218)161-65-111(199)170-93(39-30-54-159-151(156)157)129(217)164-68-118(210)211)190-140(228)103(57-84-31-20-18-21-32-84)180-135(223)99(47-51-116(206)207)175-134(222)95(38-27-29-53-153)172-125(213)79(12)166-124(212)78(11)168-133(221)98(44-48-110(155)198)171-112(200)66-162-132(220)97(46-50-115(204)205)174-136(224)100(55-73(2)3)178-137(225)102(59-86-40-42-89(197)43-41-86)181-143(231)107(69-192)184-145(233)109(71-194)185-147(235)120(76(8)9)189-142(230)106(62-117(208)209)182-144(232)108(70-193)186-150(238)123(83(16)196)191-141(229)104(58-85-33-22-19-23-34-85)183-149(237)122(82(15)195)187-113(201)67-163-131(219)96(45-49-114(202)203)173-126(214)80(13)167-128(216)91(154)61-88-64-158-72-165-88/h18-25,31-36,40-43,63-64,72-83,91,93-109,119-123,160,192-197H,17,26-30,37-39,44-62,65-71,152-154H2,1-16H3,(H2,155,198)(H,158,165)(H,161,218)(H,162,220)(H,163,219)(H,164,217)(H,166,212)(H,167,216)(H,168,221)(H,169,236)(H,170,199)(H,171,200)(H,172,213)(H,173,214)(H,174,224)(H,175,222)(H,176,234)(H,177,215)(H,178,225)(H,179,226)(H,180,223)(H,181,231)(H,182,232)(H,183,237)(H,184,233)(H,185,235)(H,186,238)(H,187,201)(H,188,227)(H,189,230)(H,190,228)(H,191,229)(H,202,203)(H,204,205)(H,206,207)(H,208,209)(H,210,211)(H4,156,157,159)/t77-,78-,79-,80-,81-,82+,83+,91-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,119-,120-,121-,122-,123-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL MMDB PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.100	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Displacement of [125I]-GLP1 from human GLP1 receptor expressed in BHK cells after 2 hrs in presence of 2% human serum albumin				J Med Chem 58: 7370-80 (2015) Article DOI: 10.1021/acs.jmedchem.5b00726 BindingDB Entry DOI: 10.7270/Q2TX3H6D
					More data for this Ligand-Target Pair
Glucagon-like peptide 1 receptor (Homo sapiens (Human))	BDBM50121401 (CHEMBL3616771) Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O |r| Show InChI InChI=1S/C188H296N48O57/c1-18-106(10)154(180(284)212-109(13)159(263)220-134(87-115-90-204-120-51-40-39-50-118(115)120)170(274)222-130(83-103(4)5)171(275)232-152(104(6)7)178(282)219-122(54-44-72-202-186(193)194)162(266)206-92-141(245)213-121(53-43-71-201-185(191)192)161(265)205-94-143(247)215-128(183(287)288)52-41-42-70-198-145(249)99-292-80-79-291-77-75-200-146(250)100-293-81-78-290-76-74-199-140(244)56-37-29-27-25-23-21-19-20-22-24-26-28-30-38-57-147(251)252)234-172(276)132(84-112-46-33-31-34-47-112)223-167(271)127(65-69-150(257)258)218-166(270)123(55-45-73-203-187(195)196)216-158(262)108(12)210-157(261)107(11)211-165(269)126(62-66-139(190)243)214-142(246)93-207-163(267)124(63-67-148(253)254)217-168(272)129(82-102(2)3)221-169(273)131(86-114-58-60-117(242)61-59-114)224-175(279)136(96-237)227-177(281)138(98-239)228-179(283)153(105(8)9)233-174(278)135(89-151(259)260)225-176(280)137(97-238)229-182(286)156(111(15)241)235-173(277)133(85-113-48-35-32-36-49-113)226-181(285)155(110(14)240)231-144(248)95-208-164(268)125(64-68-149(255)256)230-184(289)188(16,17)236-160(264)119(189)88-116-91-197-101-209-116/h31-36,39-40,46-51,58-61,90-91,101-111,119,121-138,152-156,204,237-242H,18-30,37-38,41-45,52-57,62-89,92-100,189H2,1-17H3,(H2,190,243)(H,197,209)(H,198,249)(H,199,244)(H,200,250)(H,205,265)(H,206,266)(H,207,267)(H,208,268)(H,210,261)(H,211,269)(H,212,284)(H,213,245)(H,214,246)(H,215,247)(H,216,262)(H,217,272)(H,218,270)(H,219,282)(H,220,263)(H,221,273)(H,222,274)(H,223,271)(H,224,279)(H,225,280)(H,226,285)(H,227,281)(H,228,283)(H,229,286)(H,230,289)(H,231,248)(H,232,275)(H,233,278)(H,234,276)(H,235,277)(H,236,264)(H,251,252)(H,253,254)(H,255,256)(H,257,258)(H,259,260)(H,287,288)(H4,191,192,201)(H4,193,194,202)(H4,195,196,203)/t106-,107-,108-,109-,110+,111+,119-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,152-,153-,154-,155-,156-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.110	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Displacement of [125I]-GLP1 from human GLP1 receptor expressed in BHK cells after 2 hrs in absence of human serum albumin				J Med Chem 58: 7370-80 (2015) Article DOI: 10.1021/acs.jmedchem.5b00726 BindingDB Entry DOI: 10.7270/Q2TX3H6D
					More data for this Ligand-Target Pair
Glucagon-like peptide 1 receptor (Homo sapiens (Human))	BDBM50121398 (CHEMBL3616480) Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(=O)NCC(O)=O |r| Show InChI InChI=1S/C182H284N44O56/c1-18-103(10)150(176(275)203-106(13)155(254)210-130(84-112-87-195-117-50-40-39-49-115(112)117)166(265)212-126(80-100(4)5)167(266)222-148(101(6)7)174(273)209-119(52-43-69-193-180(185)186)158(257)196-89-137(235)204-118(157(256)199-92-147(250)251)51-41-42-68-190-140(238)96-281-77-76-280-74-72-192-141(239)97-282-78-75-279-73-71-191-136(234)54-37-29-27-25-23-21-19-20-22-24-26-28-30-38-55-142(240)241)224-168(267)128(81-109-45-33-31-34-46-109)213-163(262)124(63-67-145(246)247)208-162(261)120(53-44-70-194-181(187)188)206-154(253)105(12)201-153(252)104(11)202-161(260)123(60-64-135(184)233)205-138(236)90-197-159(258)121(61-65-143(242)243)207-164(263)125(79-99(2)3)211-165(264)127(83-111-56-58-114(232)59-57-111)214-171(270)132(93-227)217-173(272)134(95-229)218-175(274)149(102(8)9)223-170(269)131(86-146(248)249)215-172(271)133(94-228)219-178(277)152(108(15)231)225-169(268)129(82-110-47-35-32-36-48-110)216-177(276)151(107(14)230)221-139(237)91-198-160(259)122(62-66-144(244)245)220-179(278)182(16,17)226-156(255)116(183)85-113-88-189-98-200-113/h31-36,39-40,45-50,56-59,87-88,98-108,116,118-134,148-152,195,227-232H,18-30,37-38,41-44,51-55,60-86,89-97,183H2,1-17H3,(H2,184,233)(H,189,200)(H,190,238)(H,191,234)(H,192,239)(H,196,257)(H,197,258)(H,198,259)(H,199,256)(H,201,252)(H,202,260)(H,203,275)(H,204,235)(H,205,236)(H,206,253)(H,207,263)(H,208,261)(H,209,273)(H,210,254)(H,211,264)(H,212,265)(H,213,262)(H,214,270)(H,215,271)(H,216,276)(H,217,272)(H,218,274)(H,219,277)(H,220,278)(H,221,237)(H,222,266)(H,223,269)(H,224,267)(H,225,268)(H,226,255)(H,240,241)(H,242,243)(H,244,245)(H,246,247)(H,248,249)(H,250,251)(H4,185,186,193)(H4,187,188,194)/t103-,104-,105-,106-,107+,108+,116-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,148-,149-,150-,151-,152-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.110	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Displacement of [125I]-GLP1 from human GLP1 receptor expressed in BHK cells after 2 hrs in absence of human serum albumin				J Med Chem 58: 7370-80 (2015) Article DOI: 10.1021/acs.jmedchem.5b00726 BindingDB Entry DOI: 10.7270/Q2TX3H6D
					More data for this Ligand-Target Pair
Glucagon-like peptide 1 receptor (Homo sapiens (Human))	BDBM50121535 (CHEMBL3616739) Show SMILES CCCCCCCCCCCCCCCC(=O)N[C@H](CCC(=O)NCCCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)C(O)=O |r| Show InChI InChI=1S/C173H267N43O51/c1-19-21-22-23-24-25-26-27-28-29-30-31-38-54-129(225)195-116(169(265)266)60-65-128(224)181-69-42-41-51-111(152(248)198-115(63-68-135(233)234)153(249)203-120(74-100-45-34-32-35-46-100)158(254)214-140(94(11)20-2)166(262)192-97(14)145(241)200-122(77-103-80-184-108-50-40-39-49-106(103)108)156(252)202-118(73-91(5)6)157(253)212-138(92(7)8)164(260)199-110(53-44-71-183-172(178)179)148(244)185-82-130(226)193-109(52-43-70-182-171(176)177)147(243)188-85-137(237)238)196-144(240)96(13)190-143(239)95(12)191-151(247)114(59-64-127(175)223)194-131(227)83-186-149(245)112(61-66-133(229)230)197-154(250)117(72-90(3)4)201-155(251)119(76-102-55-57-105(222)58-56-102)204-161(257)124(86-217)207-163(259)126(88-219)208-165(261)139(93(9)10)213-160(256)123(79-136(235)236)205-162(258)125(87-218)209-168(264)142(99(16)221)215-159(255)121(75-101-47-36-33-37-48-101)206-167(263)141(98(15)220)211-132(228)84-187-150(246)113(62-67-134(231)232)210-170(267)173(17,18)216-146(242)107(174)78-104-81-180-89-189-104/h32-37,39-40,45-50,55-58,80-81,89-99,107,109-126,138-142,184,217-222H,19-31,38,41-44,51-54,59-79,82-88,174H2,1-18H3,(H2,175,223)(H,180,189)(H,181,224)(H,185,244)(H,186,245)(H,187,246)(H,188,243)(H,190,239)(H,191,247)(H,192,262)(H,193,226)(H,194,227)(H,195,225)(H,196,240)(H,197,250)(H,198,248)(H,199,260)(H,200,241)(H,201,251)(H,202,252)(H,203,249)(H,204,257)(H,205,258)(H,206,263)(H,207,259)(H,208,261)(H,209,264)(H,210,267)(H,211,228)(H,212,253)(H,213,256)(H,214,254)(H,215,255)(H,216,242)(H,229,230)(H,231,232)(H,233,234)(H,235,236)(H,237,238)(H,265,266)(H4,176,177,182)(H4,178,179,183)/t94-,95-,96-,97-,98+,99+,107-,109-,110-,111-,112-,113-,114-,115-,116+,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,138-,139-,140-,141-,142-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.120	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Displacement of [125I]-GLP1 from human GLP1 receptor expressed in BHK cells after 2 hrs in absence of human serum albumin				J Med Chem 58: 7370-80 (2015) Article DOI: 10.1021/acs.jmedchem.5b00726 BindingDB Entry DOI: 10.7270/Q2TX3H6D
					More data for this Ligand-Target Pair
Glucagon-like peptide 1 receptor (Homo sapiens (Human))	BDBM50121400 (CHEMBL3616752) Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O |r| Show InChI InChI=1S/C187H291N45O59/c1-18-105(10)154(180(282)208-108(13)159(261)216-133(86-114-89-200-119-50-40-39-49-117(114)119)170(272)218-129(82-102(4)5)171(273)228-152(103(6)7)178(280)215-121(53-44-72-199-186(192)193)162(264)201-91-141(242)209-120(52-43-71-198-185(190)191)161(263)204-94-151(257)258)230-172(274)131(83-111-45-33-31-34-46-111)219-167(269)126(64-69-149(253)254)214-166(268)122(51-41-42-70-195-144(245)98-290-79-78-289-76-74-197-145(246)99-291-80-77-288-75-73-196-139(240)66-61-127(183(285)286)211-140(241)54-37-29-27-25-23-21-19-20-22-24-26-28-30-38-55-146(247)248)212-158(260)107(12)206-157(259)106(11)207-165(267)125(60-65-138(189)239)210-142(243)92-202-163(265)123(62-67-147(249)250)213-168(270)128(81-101(2)3)217-169(271)130(85-113-56-58-116(238)59-57-113)220-175(277)135(95-233)223-177(279)137(97-235)224-179(281)153(104(8)9)229-174(276)134(88-150(255)256)221-176(278)136(96-234)225-182(284)156(110(15)237)231-173(275)132(84-112-47-35-32-36-48-112)222-181(283)155(109(14)236)227-143(244)93-203-164(266)124(63-68-148(251)252)226-184(287)187(16,17)232-160(262)118(188)87-115-90-194-100-205-115/h31-36,39-40,45-50,56-59,89-90,100-110,118,120-137,152-156,200,233-238H,18-30,37-38,41-44,51-55,60-88,91-99,188H2,1-17H3,(H2,189,239)(H,194,205)(H,195,245)(H,196,240)(H,197,246)(H,201,264)(H,202,265)(H,203,266)(H,204,263)(H,206,259)(H,207,267)(H,208,282)(H,209,242)(H,210,243)(H,211,241)(H,212,260)(H,213,270)(H,214,268)(H,215,280)(H,216,261)(H,217,271)(H,218,272)(H,219,269)(H,220,277)(H,221,278)(H,222,283)(H,223,279)(H,224,281)(H,225,284)(H,226,287)(H,227,244)(H,228,273)(H,229,276)(H,230,274)(H,231,275)(H,232,262)(H,247,248)(H,249,250)(H,251,252)(H,253,254)(H,255,256)(H,257,258)(H,285,286)(H4,190,191,198)(H4,192,193,199)/t105-,106-,107-,108-,109+,110+,118-,120-,121-,122-,123-,124-,125-,126-,127+,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,152-,153-,154-,155-,156-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.130	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Displacement of [125I]-GLP1 from human GLP1 receptor expressed in BHK cells after 2 hrs in absence of human serum albumin				J Med Chem 58: 7370-80 (2015) Article DOI: 10.1021/acs.jmedchem.5b00726 BindingDB Entry DOI: 10.7270/Q2TX3H6D
					More data for this Ligand-Target Pair
Glucagon-like peptide 1 receptor (Homo sapiens (Human))	BDBM50121394 (CHEMBL3616711) Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O |r| Show InChI InChI=1S/C151H228N42O47/c1-17-76(10)120(147(238)171-80(14)126(217)179-104(59-86-62-162-91-35-25-24-34-89(86)91)137(228)181-100(55-73(4)5)138(229)190-118(74(6)7)145(236)178-93(38-29-53-161-151(157)158)129(220)163-64-110(201)172-92(37-28-52-160-150(155)156)128(219)166-67-117(212)213)192-139(230)102(56-83-30-20-18-21-31-83)182-134(225)98(46-50-115(208)209)177-133(224)94(36-26-27-51-152)174-124(215)78(12)168-123(214)77(11)170-132(223)97(43-47-109(154)200)173-111(202)65-164-131(222)96(45-49-114(206)207)176-135(226)99(54-72(2)3)180-136(227)101(58-85-39-41-88(199)42-40-85)183-142(233)106(68-194)186-144(235)108(70-196)187-146(237)119(75(8)9)191-141(232)105(61-116(210)211)184-143(234)107(69-195)188-149(240)122(82(16)198)193-140(231)103(57-84-32-22-19-23-33-84)185-148(239)121(81(15)197)189-112(203)66-165-130(221)95(44-48-113(204)205)175-125(216)79(13)169-127(218)90(153)60-87-63-159-71-167-87/h18-25,30-35,39-42,62-63,71-82,90,92-108,118-122,162,194-199H,17,26-29,36-38,43-61,64-70,152-153H2,1-16H3,(H2,154,200)(H,159,167)(H,163,220)(H,164,222)(H,165,221)(H,166,219)(H,168,214)(H,169,218)(H,170,223)(H,171,238)(H,172,201)(H,173,202)(H,174,215)(H,175,216)(H,176,226)(H,177,224)(H,178,236)(H,179,217)(H,180,227)(H,181,228)(H,182,225)(H,183,233)(H,184,234)(H,185,239)(H,186,235)(H,187,237)(H,188,240)(H,189,203)(H,190,229)(H,191,232)(H,192,230)(H,193,231)(H,204,205)(H,206,207)(H,208,209)(H,210,211)(H,212,213)(H4,155,156,160)(H4,157,158,161)/t76-,77-,78-,79-,80-,81+,82+,90-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,118-,119-,120-,121-,122-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.140	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Displacement of [125I]-GLP1 from human GLP1 receptor expressed in BHK cells after 2 hrs in presence of 2% human serum albumin				J Med Chem 58: 7370-80 (2015) Article DOI: 10.1021/acs.jmedchem.5b00726 BindingDB Entry DOI: 10.7270/Q2TX3H6D
					More data for this Ligand-Target Pair
Glucagon-like peptide 1 receptor (Homo sapiens (Human))	BDBM50121406 (CHEMBL3616713) Show SMILES CCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)NCCCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)C(O)=O |r| Show InChI InChI=1S/C188H295N45O57/c1-18-20-21-22-23-24-25-26-27-28-29-30-31-32-33-34-41-57-143(242)213-130(186(285)286)63-68-142(241)197-75-77-287-79-82-290-101-148(247)198-76-78-288-80-81-289-100-147(246)196-72-45-44-54-125(169(268)217-129(66-71-151(252)253)170(269)222-134(85-114-48-37-35-38-49-114)175(274)232-156(107(11)19-2)183(282)210-111(15)162(261)219-136(88-117-91-201-122-53-43-42-52-120(117)122)173(272)221-132(84-104(5)6)174(273)230-154(105(7)8)181(280)218-124(56-47-74-200-188(193)194)165(264)202-93-144(243)211-123(55-46-73-199-187(191)192)164(263)205-96-153(256)257)214-160(259)109(13)207-159(258)108(12)209-168(267)128(62-67-141(190)240)212-145(244)94-203-167(266)127(65-70-150(250)251)216-171(270)131(83-103(3)4)220-172(271)133(87-116-58-60-119(239)61-59-116)223-178(277)138(97-234)226-180(279)140(99-236)227-182(281)155(106(9)10)231-177(276)137(90-152(254)255)224-179(278)139(98-235)228-185(284)158(113(17)238)233-176(275)135(86-115-50-39-36-40-51-115)225-184(283)157(112(16)237)229-146(245)95-204-166(265)126(64-69-149(248)249)215-161(260)110(14)208-163(262)121(189)89-118-92-195-102-206-118/h35-40,42-43,48-53,58-61,91-92,102-113,121,123-140,154-158,201,234-239H,18-34,41,44-47,54-57,62-90,93-101,189H2,1-17H3,(H2,190,240)(H,195,206)(H,196,246)(H,197,241)(H,198,247)(H,202,264)(H,203,266)(H,204,265)(H,205,263)(H,207,258)(H,208,262)(H,209,267)(H,210,282)(H,211,243)(H,212,244)(H,213,242)(H,214,259)(H,215,260)(H,216,270)(H,217,268)(H,218,280)(H,219,261)(H,220,271)(H,221,272)(H,222,269)(H,223,277)(H,224,278)(H,225,283)(H,226,279)(H,227,281)(H,228,284)(H,229,245)(H,230,273)(H,231,276)(H,232,274)(H,233,275)(H,248,249)(H,250,251)(H,252,253)(H,254,255)(H,256,257)(H,285,286)(H4,191,192,199)(H4,193,194,200)/t107-,108-,109-,110-,111-,112+,113+,121-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,154-,155-,156-,157-,158-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	n/a	n/a	0.160	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Displacement of [125I]-GLP1 from human GLP1 receptor expressed in BHK cells after 2 hrs in absence of human serum albumin				J Med Chem 58: 7370-80 (2015) Article DOI: 10.1021/acs.jmedchem.5b00726 BindingDB Entry DOI: 10.7270/Q2TX3H6D
					More data for this Ligand-Target Pair
Glucagon-like peptide 1 receptor (Homo sapiens (Human))	BDBM50121531 (CHEMBL3616741) Show SMILES CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)C(O)=O |r| Show InChI InChI=1S/C179H278N44O54/c1-19-21-22-23-24-25-26-27-28-29-30-31-38-54-134(232)202-121(175(273)274)60-65-133(231)188-72-73-276-74-75-277-93-138(236)187-69-42-41-51-116(158(256)205-120(63-68-141(241)242)159(257)210-125(78-105-45-34-32-35-46-105)164(262)221-146(99(11)20-2)172(270)199-102(14)151(249)207-127(81-108-84-191-113-50-40-39-49-111(108)113)162(260)209-123(77-96(5)6)163(261)219-144(97(7)8)170(268)206-115(53-44-71-190-178(184)185)154(252)192-86-135(233)200-114(52-43-70-189-177(182)183)153(251)195-89-143(245)246)203-150(248)101(13)197-149(247)100(12)198-157(255)119(59-64-132(181)230)201-136(234)87-193-155(253)117(61-66-139(237)238)204-160(258)122(76-95(3)4)208-161(259)124(80-107-55-57-110(229)58-56-107)211-167(265)129(90-224)214-169(267)131(92-226)215-171(269)145(98(9)10)220-166(264)128(83-142(243)244)212-168(266)130(91-225)216-174(272)148(104(16)228)222-165(263)126(79-106-47-36-33-37-48-106)213-173(271)147(103(15)227)218-137(235)88-194-156(254)118(62-67-140(239)240)217-176(275)179(17,18)223-152(250)112(180)82-109-85-186-94-196-109/h32-37,39-40,45-50,55-58,84-85,94-104,112,114-131,144-148,191,224-229H,19-31,38,41-44,51-54,59-83,86-93,180H2,1-18H3,(H2,181,230)(H,186,196)(H,187,236)(H,188,231)(H,192,252)(H,193,253)(H,194,254)(H,195,251)(H,197,247)(H,198,255)(H,199,270)(H,200,233)(H,201,234)(H,202,232)(H,203,248)(H,204,258)(H,205,256)(H,206,268)(H,207,249)(H,208,259)(H,209,260)(H,210,257)(H,211,265)(H,212,266)(H,213,271)(H,214,267)(H,215,269)(H,216,272)(H,217,275)(H,218,235)(H,219,261)(H,220,264)(H,221,262)(H,222,263)(H,223,250)(H,237,238)(H,239,240)(H,241,242)(H,243,244)(H,245,246)(H,273,274)(H4,182,183,189)(H4,184,185,190)/t99-,100-,101-,102-,103+,104+,112-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,144-,145-,146-,147-,148-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.160	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Displacement of [125I]-GLP1 from human GLP1 receptor expressed in BHK cells after 2 hrs in absence of human serum albumin				J Med Chem 58: 7370-80 (2015) Article DOI: 10.1021/acs.jmedchem.5b00726 BindingDB Entry DOI: 10.7270/Q2TX3H6D
					More data for this Ligand-Target Pair
Glucagon-like peptide 1 receptor (Homo sapiens (Human))	BDBM50121527 (CHEMBL3616718) Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O |r| Show InChI InChI=1S/C152H230N42O47/c1-18-77(10)120(146(238)171-80(13)125(217)178-104(60-86-63-163-91-36-26-25-35-89(86)91)136(228)180-100(56-74(4)5)137(229)190-118(75(6)7)144(236)177-93(39-30-54-162-151(158)159)128(220)164-65-110(202)172-92(38-29-53-161-150(156)157)127(219)167-68-117(213)214)192-138(230)102(57-83-31-21-19-22-32-83)181-133(225)98(47-51-115(209)210)176-132(224)94(37-27-28-52-153)174-124(216)79(12)169-123(215)78(11)170-131(223)97(44-48-109(155)201)173-111(203)66-165-129(221)95(45-49-113(205)206)175-134(226)99(55-73(2)3)179-135(227)101(59-85-40-42-88(200)43-41-85)182-141(233)106(69-195)185-143(235)108(71-197)186-145(237)119(76(8)9)191-140(232)105(62-116(211)212)183-142(234)107(70-196)187-148(240)122(82(15)199)193-139(231)103(58-84-33-23-20-24-34-84)184-147(239)121(81(14)198)189-112(204)67-166-130(222)96(46-50-114(207)208)188-149(241)152(16,17)194-126(218)90(154)61-87-64-160-72-168-87/h19-26,31-36,40-43,63-64,72-82,90,92-108,118-122,163,195-200H,18,27-30,37-39,44-62,65-71,153-154H2,1-17H3,(H2,155,201)(H,160,168)(H,164,220)(H,165,221)(H,166,222)(H,167,219)(H,169,215)(H,170,223)(H,171,238)(H,172,202)(H,173,203)(H,174,216)(H,175,226)(H,176,224)(H,177,236)(H,178,217)(H,179,227)(H,180,228)(H,181,225)(H,182,233)(H,183,234)(H,184,239)(H,185,235)(H,186,237)(H,187,240)(H,188,241)(H,189,204)(H,190,229)(H,191,232)(H,192,230)(H,193,231)(H,194,218)(H,205,206)(H,207,208)(H,209,210)(H,211,212)(H,213,214)(H4,156,157,161)(H4,158,159,162)/t77-,78-,79-,80-,81+,82+,90-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,118-,119-,120-,121-,122-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	0.170	n/a	n/a	n/a	n/a	n/a	n/a
Novo Nordisk A/S Curated by ChEMBL					Assay Description Displacement of [125I]-GLP1 from human GLP1 receptor expressed in BHK cells after 2 hrs in absence of human serum albumin				J Med Chem 58: 7370-80 (2015) Article DOI: 10.1021/acs.jmedchem.5b00726 BindingDB Entry DOI: 10.7270/Q2TX3H6D
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 585 total )  |  Next  |  Last  >>

Jump to: